Coral Laboratories Up 1% After Completing Ointment Unit Capacity Expansion at Dehradun PlantCoral Laboratories Up 1% After Completing Ointment Unit Capacity Expansion at Dehradun Plant

Introduction

Leading pharmaceutical formulations manufacturer announced successful completion of its ointment unit capacity expansion at the Dehradun plant and commencement of commercial operations at the expanded facility.

Also Read: Ashok Leyland to Invest ₹375 Crore in UK Subsidiary Optare

Share Price Movement of Coral Laboratories Ltd.

On March 24, 2026, Coral Laboratories Ltd opened at 409.70 and traded between a high of 417.00 and a low of 382.25, with a VWAP of 393.86. It has a 52-week range of 382.25–784.55 and a market cap of ₹138.31 crore.

Ointment Unit Expansion Completed

Coral Laboratories Limited announced on March 23, 2026 the successful completion of capacity expansion at its Dehradun plant. The General Pharmaceuticals Formulation (Ointment) unit has been expanded to a capacity of 360,000 kgs. The company had initially intimated about this capacity expansion on October 13, 2025.

The company has commenced commercial operations at the expanded facility. This expansion strengthens Coral Laboratories’ manufacturing capabilities in topical pharmaceutical formulations for domestic and export markets.

Coral Laboratories is an ISO 9001:2008 certified manufacturer and exporter of pharmaceutical formulations including tablets, capsules, liquid, and topical preparations. The company focuses on generics and patent non-infringing products for emerging markets.

Stock performance of Coral Laboratories Ltd.  for Period of 1 week, 6 months, and 1 year

Coral Laboratories Ltd delivered a -week return of -8.31%, a 6-month return of -26.4%, and a 1-year return of -47.4%.

Also Read: Thomas Cook to Demerge Resorts Business into Sterling Holiday Resorts

Shareholding pattern of Coral Laboratories Ltd.

Particulars	Mar 2025	Jun 2025	Sep 2025
Promoter	71.50%	71.50%	71.50%
FII	0%	0%	0%
DII	0%	0%	0%
Public	28.50%	28.50%	28.50%

About Coral Laboratories Ltd.

Coral Laboratories Ltd (BSE: 524506) is an ISO 9001:2008 certified manufacturer and exporter of pharmaceutical formulations including tablets, capsules, liquid, and topical preparations for emerging markets.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs